bpc 157 thymosin beta 4 BPC-157 & TB-500 Peptide Therapy in Newport Beach, CA BPC-157 + TB-500: Tissue Regeneration
Description
The SELECT trial demonstrated semaglutides cardiovascular benefits

The theoretical concern with BPC-157 follows a similar pattern: biological plausibility exists, but demonstrable risk has not materialized

There is no downtime involved with the injections

Herein lies the problem

However, its clinical application must be approached with a critical and nuanced understanding of the current evidence gap